Practice Areas & Industries: Greenberg Traurig, LLP

 




Intellectual Property LitigationReturn to Practice Areas & Industries

Group Profile Lawyers in this Group Offices Locations for this Group
 

Practice/Industry Group Overview

For today’s corporations, intellectual property can be a source of both major revenue and considerable risk. As infringement and counterfeiting cases have become more and more common, companies have seen the potential costs involved in protecting their IP rights rise dramatically. Companies need IP management strategies designed for maximum protection. However, when litigation is unavoidable, they can also draw on Greenberg Traurig’s experienced IP litigation team.

Enforcing IP rights against infringement often requires quick and decisive action to secure injunctive relief and skillful advocacy to recover monetary damages. GT provides IP enforcement with both the wide-ranging experience of a boutique and the staff and resources of an international firm. With experience in federal and state court litigation of patent, trademark, trade dress, trade secret and copyright infringement, as well as in computer software-related disputes, we have handled some of the most complex IP cases.


 

Services Available

Patent Litigation

  • Prosecute and defend patent litigation matters in U.S. federal district courts throughout the United States on behalf of highly diverse clients – from small private companies to some of the world’s leading corporations and institutions
     
  • Provide clients with the benefit of our experience arguing cases at the Court of Appeals for the Federal Circuit, which hears all patent appeals from district courts around the United States
     
  • Tailor litigation strategies to meet each client’s business needs and objectives

Trademark Litigation

  • Protect clients’ rights in trademarks and trade dress through instruction, investigation and negotiation
     
  • Conduct complex litigation involving trademark licensing issues, parallel trade, trademark infringement, trademark counterfeiting, trade dress infringement, trademark dilution, false advertising, copyright infringement and rights of publicity
     
  • Resolve problems in difficult jurisdictions across Asia, the Americas, Europe and elsewhere with an established worldwide network to implement global brand protection programs on a fast, economical and effective basis
     
  • Handle the many phases of litigation, including applications for emergency injunctive relief (temporary restraining orders, preliminary injunctions, seizures), declaratory judgment proceedings, trials and appeals, in federal courts throughout the United States and in judicial tribunals around the world

Copyright Litigation

  • Regularly defend clients in the technology, media and entertainment industries
     
  • Represent clients in some of the most sophisticated cases in the courts today involving landmark issues such as entertainers’ rights of publicity and the liability of online service providers for IP violations occurring on their websites
     
  • Draw on the capabilities of GT’s international and domestic copyright practice, which focuses on securing copyright registrations to protect original works of authorship and handles development, licensing and distribution for books, music, film, sound recordings, software, new media, photography, art and multimedia

 
 
Articles Authored by Lawyers at this office:

Heartburn for Drug Manufacturers: 'Reverse Payment' That Did Not Include a Monetary Payment Held Actionable Under the Antitrust Laws
John J. Elliott,Irving Scher, November 21, 2013
On July 17, 2013, the Supreme Court of the United States resolved a decade of conflicting circuit court decisions in FTC v. Actavis, Inc., ruling that "reverse-payment" settlements of Hatch-Waxman Act patent infringement lawsuits "can sometimes violate the antitrust laws," and...

New HSR Rules Will Require More Filings for Pharmaceutical Patent Transfers: Increased Review Raises Importance of Valuation
Mary K. Marks, November 11, 2013
Amendments to the Rules under the Hart-Scott-Rodino (HSR) Act have been adopted that will require compliance with the Act’s reporting and waiting period requirements for certain acquisitions of exclusive pharmaceutical patent licenses that historically have not been reportable because the...

Supreme Court Rules That Reverse-Payment Patent Litigation Settlements are Subject to Judicial Review Under the Antitrust Rule of Reason
John J. Elliott, August 22, 2013
On June 17th, the U.S. Supreme Court resolved a decade of conflicting circuit court opinions when it held in Federal Trade Commission v. Actavis, Inc., that “reverse-payment” settlements of Hatch-Waxman Act patent lawsuits “can sometimes violate the antitrust laws,” and for...

The European Commission’s Measures on Actions for Damages Caused by Infringements of the Competition Law Provisions
Francesco Mazzocchi, August 22, 2013
On June 11, 2013, the European Commission (Commission) released a proposal for a directive on actions for damages for infringements of EU and national competition law (the Directive). The Directive was accompanied by a practical guide on the quantification of harm and a recommendation on collective...

China's Patent Re-Examination Board Says Pharmaceutical Salts Not Patentable Over Pure Compounds
Weisun Rao, August 16, 2013
In July 2013, the Patent Re-Examination Board of China’s State Intellectual Property Office invalidated the U.S. biotech company, Gilead Sciences’, Chinese patent covering Tenofovir Disoproxil Fumarate (TDF or PMPA), which is the active ingredient in Gilead Sciences’ drug for...

Dutch Data Protection Regime to be Enhanced by Proposed Mandatory Data Breach Notifications in Parallel with EU Efforts to Harmonize Notification of Personal Data Breaches
Emilie van Hasselt, July 30, 2013
In June 2013, the Netherlands introduced a legislative proposal to impose mandatory data breach notifications that gives the Dutch Data Protection Authority (DPA) the power to impose substantial fines for failure to comply with the new requirements.